Z39Ig Antibody (6H8): sc-53977. Western blot analysis of Z39Ig expression in untreated (A) and chemically-treated (B, C) A549 whole cell lysates. β-Actin (C4): sc-47778 used as loading control. Detection reagent used: m-IgG Fc BP-HRP: sc-525409.
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
Z39Ig Antibody (6H8): sc-53977. Western blot analysis of Z39Ig expression in untreated (A) and chemically-treated (B, C) A549 whole cell lysates. β-Actin (C4): sc-47778 used as loading control. Detection reagent used: m-IgG Fc BP-HRP: sc-525409.
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
200 µl of transduction-ready, high-titer CRISPR/dCas9 Lentiviral Activation Particles
Z39Ig Lentiviral Activation Particles (h) is a synergistic activation mediator (SAM) transcription activation system designed to specifically and efficiently upregulate gene expression via lentiviral transduction of cells
Z39Ig Lentiviral Activation Particles (h) contain the following SAM Activation elements: a deactivated Cas9 (dCas9) nuclease (D10A and N863A) fused to the transactivation domain VP64, an MS2-p65-HSF1 fusion protein and a target-specific 20 nt guide RNA. They also contain the blasticidin, hygromycin and puromycin resistance genes
Upon transduction, the SAM complex binds to a site-specific region approximately 200-250 nt upstream of the transcriptional start site and provides robust recruitment of transcription factors for highly efficient gene activation
gRNAs encoded by Z39Ig Lentiviral Activation Plasmid (h) and Z39Ig Lentiviral Activation Plasmid (h2) target distinct regulatory regions of the VSIG4 promoter. One or both designs may be available
Following transfection, gene activation efficiency can be assayed by WB, IF or IHC using antibody: Z39Ig Antibody (6H8): sc-53977